Eurizon Capital SGR S.p.A.
Institutional investor · Portfolio as of Q4 2025
Top Holdings1,090 positions
NVIDIA Corp. | 14M | $2.6B | 8.1% | $186.06 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp. | 4.2M | $2B | 6.4% | $480.57 | 0.00% | 1 qtr | First report 0 |
Apple Inc. | 7.3M | $2B | 6.2% | $271.12 | 0.00% | 1 qtr | First report 0 |
Amazon.com, Inc. | 5.4M | $1.3B | 3.9% | $232.53 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc. | 3.2M | $1B | 3.2% | $313.19 | 0.00% | 1 qtr | First report 0 |
Broadcom Inc | 2.8M | $977.4M | 3.0% | $344.83 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc. | 2.6M | $808.8M | 2.5% | $312.39 | 0.00% | 1 qtr | First report 0 |
Tesla Inc | 1.5M | $659.7M | 2.1% | $449.72 | 0.00% | 1 qtr | First report 0 |
Meta Platforms Inc | 979,613 | $647.4M | 2.0% | $658.40 | 0.00% | 1 qtr | First report 0 |
Eli Lilly & Co. | 528,895 | $568.8M | 1.8% | $1,069.51 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 1.9M | $397.8M | 1.2% | $203.67 | 0.00% | 1 qtr | First report 0 |
BK OF AMERICA CORP | 6.7M | $371.5M | 1.2% | $54.13 | 0.00% | 1 qtr | First report 0 |
AbbVie Inc. | 1.6M | $355.5M | 1.1% | $223.21 | 0.00% | 1 qtr | First report 0 |
Lowes Companies, Inc. | 1.3M | $308.7M | 1.0% | $237.47 | 0.00% | 1 qtr | First report 0 |
CITIGROUP INC | 2.6M | $298.1M | 0.9% | $114.95 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co. | 865,031 | $278.8M | 0.9% | $317.71 | 0.00% | 1 qtr | First report 0 |
Merck & Co., Inc | 2.5M | $264.6M | 0.8% | $103.13 | 0.00% | 1 qtr | First report 0 |
Coca-Cola Co (The) | 3.7M | $260.9M | 0.8% | $68.58 | 0.00% | 1 qtr | First report 0 |
KLA Corp. | 211,356 | $257.9M | 0.8% | $121.06 | 0.00% | 1 qtr | First report 0 |
ADVANCED MICRO DEVICES INC | 1.2M | $256.5M | 0.8% | $214.16 | 0.00% | 1 qtr | First report 0 |
Eurizon Capital SGR S.p.A. manages $32.1B across 1090 positions as of Q4 2025. Top holdings: NVDA (8.1%), MSFT (6.4%), AAPL (6.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.
First quarter we have for this fund: 1090 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $32.1B across 1090 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR